Nurr1 is not essential for the development of prepulse inhibition deficits induced by prenatal immune activation

Brain, Behavior, and Immunity

Volumn 25, Issue 7, 2011, Pages 1316-1321

  Vuillermot, Stéphanie ^a   Feldon, Joram ^a   Meyer, Urs ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Cytokines; Dopamine; Infection; Maternal immune activation; Schizophrenia

Indexed keywords

NUCLEAR RECEPTOR RELATED FACTOR 1;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; GESTATIONAL AGE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; IMMUNOSTIMULATION; INFECTION; MALE; MESENCEPHALON; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEUROPATHOLOGY; NONHUMAN; PRENATAL PERIOD; PREPULSE INHIBITION; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCHIZOPHRENIA; SUBSTANTIA NIGRA; WILD TYPE;

ACOUSTIC STIMULATION; ANIMALS; BRAIN; FEMALE; MICE; MICE, KNOCKOUT; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; POLY I-C; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; STARTLE REACTION;

EID: 80052770352     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.06.012     Document Type: Article

References (31)

1. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 2001, 156:234-258.
2. Brown A.S., Derkits E.J. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am. J. Psychiatry 2010, 167:261-280.
3. Dickerson D.D., Wolff A.R., Bilkey D.K. Abnormal long-range neural synchrony in a maternal immune activation animal model of schizophrenia. J. Neurosci. 2010, 30:12424-12431.
4. Eells J.B., Misler J.A., Nikodem V.M. Early postnatal isolation reduces dopamine levels, elevates dopamine turnover and specifically disrupts prepulse inhibition in Nurr1-null heterozygous mice. Neuroscience 2006, 140:1117-1126.
5. Geyer M.A., Swerdlow N.R. Measurement of startle response, prepulse inhibition and habituation. Curr. Protoc Neurosci. 1998, 8:1-15.
6. Gilmore J.H., Jarskog L.F. Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia. Schizophr. Res. 1997, 24:365-367.
7. Girard S., Tremblay L., Lepage M., Sébire G. IL-1 receptor antagonist protects against placental and neurodevelopmental defects induced by maternal inflammation. J. Immunol. 2010, 184:3997-4005.
8. Jiang C., Wan X., He Y., Pan T., Jankovic J., Le W. Age-dependent dopaminergic dysfunction in Nurr1 knockout mice. Exp. Neurol. 2005, 191:154-162.
9. Kadkhodaei B., Ito T., Joodmardi E., Mattsson B., Rouillard C., Carta M., Muramatsu S., Sumi-Ichinose C., Nomura T., Metzger D., Chambon P., Lindqvist E., Larsson N.G., Olson L., Björklund A., Ichinose H., Perlmann T. Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons. J. Neurosci. 2009, 29:15923-15932.
10. Kimura M., Toth L.A., Agostini H., Cady A.B., Majde J.A., Krueger J.M. Comparison of acute phase responses induced in rabbits by lipopolysaccharide and double-stranded RNA. Am. J. Physiol. 1994, 267:1596-1605.
11. Le W., Conneely O.M., Zou L., He Y., Saucedo-Cardenas O., Jankovic J., Mosier D.R., Appel S.H. Selective agenesis of mesencephalic DA neurons in Nurr1-deficient mice. Exp. Neurol. 1999, 159:451-458.
12. Meyer U., Engler A., Weber L., Schedlowski M., Feldon J. Preliminary evidence for a modulation of fetal dopaminergic development by maternal immune activation during pregnancy. Neuroscience 2008, 154:701-709.
13. Meyer U., Feldon J. Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog. Neurobiol. 2010, 90:285-326.
14. Meyer U., Feldon J., Schedlowski M., Yee B.K. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci. Biobehav. Rev. 2005, 29:913-947.
15. Meyer U., Feldon J., Yee B.K. A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr. Bull. 2009, 35:959-972.
16. Meyer U., Murray P.J., Urwyler A., Yee B.K., Schedlowski M., Feldon J. Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling. Mol. Psychiatry 2008, 13:208-221.
17. Perry W., Minassian A., Feifel D., Braff D.L. Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania. Biol. Psychiatry 2001, 50:418-424.
18. Perry W., Minassian A., Lopez B., Maron L., Lincoln A. Sensorimotor gating deficits in adults with autism. Biol. Psychiatry 2007, 61:482-486.
19. Saucedo-Cardenas O., Quintana-Hau J.D., Le W.D., Smidt M.P., Cox J.J., De Mayo F., Burbach J.P., Conneely O.M. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl. Acad. Sci. USA 1998, 95:4013-4018.
20. Shi L., Fatemi S.H., Sidwell R.W., Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci. 2003, 23:297-302.
21. Smidt M.P., Burbach J.P. How to make a mesodiencephalic dopaminergic neuron. Nat. Rev. Neurosci. 2007, 8:21-32.
22. Smith S.E., Li J., Garbett K., Mirnics K., Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci. 2007, 27:10695-10702.
23. Swerdlow N.R., Benbow C.H., Zisook S., Geyer M.A., Braff D.L. A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biol. Psychiatry 1993, 33:298-301.
24. Swerdlow N.R., Geyer M.A., Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 2001, 156:194-215.
25. Swerdlow N.R., Paulsen J., Braff D.L., Butters N., Geyer M.A., Swenson M.R. Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. J. Neurol. Neurosurg. Psychiatry 1995, 58:192-200.
26. Traynor T.R., Majde J.A., Bohnet S.G., Krueger J.M. Intratracheal double-stranded RNA plus interferon-gamma: a model for analysis of the acute phase response to respiratory viral infections. Life Sci. 2004, 74:2563-2576.
27. Vuillermot, S., Joodmardi, E., Perlmann, T., Ögren, S.O., Feldon, J., Meyer, U., in press. Schizophrenia-relevant behaviors in a genetic mouse model of constitutive Nurr1 deficiency. Genes Brain Behav. in press. [Epub ahead of print] (PMID: 21545404).
28. Vuillermot S., Weber L., Feldon J., Meyer U. A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia. J. Neurosci. 2010, 30:1270-1287.
29. Wolff A.R., Bilkey D.K. Immune activation during mid-gestation disrupts sensorimotor gating in rat offspring. Behav. Brain Res. 2008, 190:156-159.
30. Zetterström R.H., Solomin L., Jansson L., Hoffer B.J., Olson L., Perlmann T. Dopamine neuron agenesis in Nurr1-deficient mice. Science 1997, 276:248-250.
31. Zetterström R.H., Williams R., Perlmann T., Olson L. Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system. Brain Res. Mol. Brain Res. 1996, 41:111-120.